Sesame GLP-1: What the Program Includes and How It Works

This article is part of the PlexusDx Education Hub — evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetics that shape every metabolic decision. Browse all Peptides & GLP-1 education

This is an independent editorial review. PlexusDx has no commercial ties to Sesame or its parent company, and nothing here is a paid or affiliate placement.

A search for “Sesame GLP-1” usually means one thing: you want to know exactly what the GLP-1 side of a marketplace telehealth service involves — which compounds are in play, how the prescription is issued, and what the visit actually delivers. This review breaks down the GLP-1 program specifically, as of April 2026, and closes on the genetic layer beneath any GLP-1 decision. Fair-balance framing, not a buying nudge.

What “GLP-1 through Sesame” actually means

Sesame (Sesame Care) is a marketplace that connects patients with independent licensed providers. On the GLP-1 side, that means a clinician can evaluate you and, if you qualify, write a prescription for a GLP-1 medication — routed either to a retail pharmacy for an FDA-approved brand or to a 503A compounding pharmacy for compounded semaglutide or tirzepatide. The structure and pricing live on Sesame’s official website.

The compounds behind a GLP-1 prescription

The label “GLP-1” covers a specific pharmacology. Semaglutide, liraglutide, and dulaglutide are GLP-1 receptor agonists; tirzepatide is a GIP/GLP-1 dual agonist that adds a second incretin target. All of them slow gastric emptying, blunt post-meal glucose spikes, and amplify satiety signaling. Which compound a program can offer depends on its pharmacy partnerships and whether the route is branded-retail or compounded.

From intake to prescription: the GLP-1 workflow

The GLP-1 pathway follows a familiar sequence: you submit an intake form with weight, medical history, and current medications; a licensed clinician reviews it and issues a prescription when eligibility is met; the order is fulfilled by a retail or 503A compounding pharmacy; and follow-up visits help manage titration and side effects. Differences across services show up in provider type — physician versus NP or PA — and in how the subscription bundles those follow-ups.

Reading the GLP-1 trial evidence

The clinical backbone of any GLP-1 program is its trial record. The STEP program studied semaglutide for weight management (NEJM, 2021), SURMOUNT studied tirzepatide for weight management (NEJM, 2022), and SURMOUNT-OSA studied tirzepatide for obstructive sleep apnea (NEJM, 2024). Because each trial used different populations and endpoints, the evidence is most honestly read one study at a time, and individual outcomes still vary.

The genetic layer under every GLP-1 prescription

No GLP-1 intake form asks about the genes that shape how your metabolism is wired. Variants in FTO (fat-mass and obesity-associated), GLP1R (the GLP-1 receptor gene itself), MC4R (satiety and energy balance), and TCF7L2 (glucose homeostasis and GLP-1 secretion) map the metabolic baseline every GLP-1 compound has to work within. They are pathway-level markers: they do not predict your response to a given medication, but they describe the biology a prescription is entering.

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — available as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. What distinguishes the approach is upstream context: before any GLP-1 protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including FTO, GLP1R, MC4R, and TCF7L2 that shape your baseline GLP-1, appetite-regulation, and energy-balance biology. That is the test before you invest approach, turning guesswork into an informed conversation with your provider.

Not affiliated: PlexusDx is not affiliated with Sesame and has no commercial relationship with the companies reviewed in this article.

Related reading on PlexusDx: GLP 1 Hormone, What Is GLP 1, GLP 1 What Is, GLP 1 Receptor Agonist.

Disclaimer: This article is educational. PlexusDx is not affiliated with Sesame and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols — this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Start upstream: take the Precision Peptide Genetic Test to understand your GLP-1 pathway, or explore the Weight Management Protocols for semaglutide and tirzepatide with genetic context.

Frequently Asked Questions

Which GLP-1 compounds might a program like Sesame prescribe?

Depending on the provider and pharmacy partner, a GLP-1 prescription may involve semaglutide or tirzepatide, either as an FDA-approved brand from a retail pharmacy or as a compounded preparation from a 503A pharmacy. Liraglutide and dulaglutide are also GLP-1-class options. Availability varies by service and by state.

Is compounded GLP-1 different from the branded version?

Yes. A compounded semaglutide or tirzepatide is prepared by a 503A compounding pharmacy under a different regulatory framework than an FDA-approved branded product dispensed by a retail pharmacy. Both can be legitimate routes, but they differ in oversight and availability. Verify the pathway your prescription follows before you commit.

Does the Precision Peptide Genetic Test predict my GLP-1 response?

No. The test does not predict response to any GLP-1 medication or telehealth program. It analyzes pathway-level variants in FTO, GLP1R, MC4R, and TCF7L2 that describe your baseline GLP-1 biology — upstream context that holds regardless of which service prescribes a compound or which compound is chosen.

What does a GLP-1 follow-up visit cover?

Follow-up in a GLP-1 program generally supports dose titration and side-effect management, since gastrointestinal symptoms are most pronounced during escalation. How often those visits occur, and whether they are bundled into the subscription, differs by service — check the specifics on the provider’s own site before enrolling.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education